LADIRUBICIN
UNII U395ERO49H

Substance Identification & Data

This profile provides standardized clinical and technical data for Ladirubicin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U395ERO49H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 171047-47-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

U395ERO49H

CAS Registry Number

171047-47-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LADIRUBICIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H31NO11S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

VMDWTZZCNDEKIO-CBNJBKGYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C83861

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

216232

Unique identification number in the NCBI database of chemical substances.

INN ID

7958

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12c(C(=O)c3c(C1=O)cccc3)c(O)c4c(c2O)C[C@](C[C@@H]4O[C@]5(C[C@H](N6CC6)[C@@H]([C@@H](O5)C)OS(=O)(=O)C)[H])(C(=O)C)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ladirubicin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LADIRUBICIN

Common Names & Synonyms

(1S,3S-3-ACETYL-1,2,3,4,6,11,HEXAHYDRO-3,5,12-TRIHYDROXY-6,11-DIOXO-1-NAPHTHACENYL 3-(1-AZIRIDINYL)-2,3,6-TRIDEOXY-4-O-(METHYLSULFONYL)-.ALPHA.-L-LYXO-HEXOPYRANOSIDE

LADIRUBICIN [INN]

LADIRUBICIN [WHO-DD]